Literature DB >> 20160140

Activation of EphA receptors on CD4+CD45RO+ memory cells stimulates migration.

H L Holen1, K Nustad, H-C Aasheim.   

Abstract

We have demonstrated previously that binding of ephrin-A1 to EphA receptors on human CD4(+) and CD8(+) T cells stimulates migration. Two EphA receptors have been reported in T cells: EphA1 at the protein level and EphA4 at the mRNA level. In this study, we wanted to investigate the expression profile of these receptors in T cell subpopulations and to test if expression differences would affect the potential of cells to migrate upon ephrin-A1 binding. We have generated an anti-EphA4 mAb for expression analysis. Our data show that functional EphA4 is expressed on the cell surface of CD4(+) and CD8(+) T cells. In addition, EphA4 receptor expression is induced after overnight incubation in serum-free medium, in particular, on CD4(+)CD45RO(+) T cells. Migration of CD4(+) T cells in response to ephrin-A1 is observed for memory cells (CD45RO(+)) and much weaker for naïve cells (CD45RA(+)). A signaling complex associated with the EphA4 receptor has also been isolated and includes EphA1, the Src family kinases Fyn and Lck, Slp76, and Vav1. To conclude, T cells express EphA1 and EphA4 receptors. Expression differences of EphA4 are observed in subpopulations of CD4(+) T cells. This is related to the cell migration potential after ephrin-A1 binding.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20160140     DOI: 10.1189/jlb.0709497

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  20 in total

Review 1.  The genetics and neuropathology of Alzheimer's disease.

Authors:  Gerard D Schellenberg; Thomas J Montine
Journal:  Acta Neuropathol       Date:  2012-05-23       Impact factor: 17.088

Review 2.  Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Biochem Pharmacol       Date:  2014-01-04       Impact factor: 5.858

3.  Intramyocardial administration of chimeric ephrinA1-Fc promotes tissue salvage following myocardial infarction in mice.

Authors:  Jessica L Dries; Susan D Kent; Jitka A I Virag
Journal:  J Physiol       Date:  2011-01-31       Impact factor: 5.182

Review 4.  Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities.

Authors:  Christiane Reitz
Journal:  Expert Rev Mol Diagn       Date:  2015-01-29       Impact factor: 5.225

Review 5.  Eph Receptor Tyrosine Kinases in Tumor Immunity.

Authors:  Eileen Shiuan; Jin Chen
Journal:  Cancer Res       Date:  2016-11-03       Impact factor: 12.701

6.  Efnb1 and Efnb2 proteins regulate thymocyte development, peripheral T cell differentiation, and antiviral immune responses and are essential for interleukin-6 (IL-6) signaling.

Authors:  Hongyu Luo; Tania Charpentier; Xuehai Wang; Shijie Qi; Bing Han; Tao Wu; Rafik Terra; Alain Lamarre; Jiangping Wu
Journal:  J Biol Chem       Date:  2011-10-05       Impact factor: 5.157

Review 7.  Lessons learned from gene expression profiling of cutaneous T-cell lymphoma.

Authors:  B O Dulmage; L J Geskin
Journal:  Br J Dermatol       Date:  2013-12       Impact factor: 9.302

8.  Differential gene expression in the EphA4 knockout spinal cord and analysis of the inflammatory response following spinal cord injury.

Authors:  Kathryn M Munro; Victoria M Perreau; Ann M Turnley
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

9.  EPHA5 mutation predicts the durable clinical benefit of immune checkpoint inhibitors in patients with lung adenocarcinoma.

Authors:  Weimei Huang; Anqi Lin; Peng Luo; Yuchen Liu; Wentao Xu; Weiliang Zhu; Ting Wei; Qingwen Lyu; Linlang Guo; Jian Zhang
Journal:  Cancer Gene Ther       Date:  2020-08-06       Impact factor: 5.987

10.  EphA4 receptor tyrosine kinase is a modulator of onset and disease severity of experimental autoimmune encephalomyelitis (EAE).

Authors:  Kathryn M Munro; Kirsty J Dixon; Melissa M Gresle; Anna Jonas; Dennis Kemper; William Doherty; Louis J Fabri; Catherine M Owczarek; Martin Pearse; Andrew W Boyd; Trevor J Kilpatrick; Helmut Butzkueven; Ann M Turnley
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.